The following is a summary of “Endocrine response in cardiogenic shock complicating myocardial infarction: the prognostic value of growth hormone and IGF-1,” published in the May 2025 issue of Journal ...

Delays in providing first medical contact to device time for STEMI can result in worse patient outcomes, highlighting the ...

Bottom line of study: SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney ...

Background: Major noncardiac surgery carries high rates of postoperative myocardial injury and other complications. Remote ischemic preconditioning (RIPC) was reported to decrease these complications.

SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there ...

Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. has divulged compounds acting as apolipoprotein A (ApoA; LPA) inhibitors reported to be useful for the treatment of hyperlipidemia, ...

A heart attack, also known as myocardial infarction, occurs when blood flow to a portion of the heart suddenly gets blocked, ...

Department of Chemistry, International Institute for Nanotechnology, Simpson-Querrey Institute, Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois 60208, United States ...

Researchers from the Germans Trias i Pujol research institute (IGTP) have conducted a preclinical study on the effects of the ...

Patients with AAV are associated with an increased risk for MI, particularly during the first 3 months after diagnosis.

Prophylactic use of nonsteroidal anti-inflammatory drugs posed higher cardiovascular risk than colchicine or no prophylaxis ...

gHeart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, and Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain ...